Macquarie Group’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-900
Closed -$7K 1696
2018
Q4
$7K Buy
+900
New +$7.54K ﹤0.01% 1985
2017
Q4
Sell
-6,800
Closed -$97K 2386
2017
Q3
$97K Buy
+6,800
New +$85.2K ﹤0.01% 1920
2015
Q1
Sell
-471,957
Closed -$5.89M 1569
2014
Q4
$5.89M Buy
471,957
+74,236
+19% +$758K 0.01% 670
2014
Q3
$3.69M Buy
397,721
+87,471
+28% +$671K 0.01% 806
2014
Q2
$2.02M Buy
310,250
+36,690
+13% +$243K ﹤0.01% 1033
2014
Q1
$2.21M Buy
273,560
+71,750
+36% +$706K ﹤0.01% 982
2013
Q4
$2.01M Buy
201,810
+18,985
+10% +$132K ﹤0.01% 982
2013
Q3
$1.11M Sell
182,825
-7,190
-4% -$41.2K ﹤0.01% 1141
2013
Q2
$980K Buy
+190,015
New +$974K ﹤0.01% 1159

Other funds holding CCRN

Macquarie Group's CCRN Position: Q1 2019 in Review

Macquarie Group sold out of Cross Country Healthcare (CCRN) in Q1 2019, closing a stake of 900 shares — an estimated $7K sold.

Macquarie Group first reported a position in CCRN in Q2 2013 and held it in 9 quarters. The position peaked at $5.89M in Q4 2014. 131 funds tracked by Wall St. Rank hold CCRN as of Q1 2019.

  • Macquarie Group reported no remaining Cross Country Healthcare position as of Q1 2019 after selling out during the quarter.
  • Macquarie Group sold 900 Cross Country Healthcare shares in Q1 2019, an estimated $7K.
  • Macquarie Group first reported a position in Cross Country Healthcare in Q2 2013 and held it in 9 quarters.
  • Macquarie Group's Cross Country Healthcare position peaked at $5.89M in Q4 2014.
  • 131 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.